What does "AI visibility" mean for my business?

When someone asks ChatGPT, Claude, or Gemini "what is the best..." or "where can I find...", AI gives specific recommendations. AI visibility is a measure of how often — and how positively — these AI platforms mention your business. It's the new version of being on the first page of Google, except now there are no pages — just one answer.

Which AI platforms do you monitor?

Pendium monitors ChatGPT, Claude, Gemini, Grok, Perplexity, DeepSeek, and Google AI Overviews — seven major AI platforms that consumers use to research local services. We run real queries that your customers actually ask and analyze the responses for mentions of your business, competitors, and industry topics.

How does Pendium improve my visibility?

Three ways. First, we identify the exact queries and topics where you're invisible. Second, we generate AI-optimized content — articles, guides, social posts — designed to help AI agents understand your business and recommend your services to the right people. Third, we continuously monitor to track improvement and find new opportunities. Most clients see measurable improvement within 60 days.

How long until I see results?

You'll get your first visibility report within minutes of signing up. Actual visibility improvement varies, but our clients typically see a 47% average improvement within 60 days. Some see results faster — it depends on your current online presence and how competitive your local market is.

Do I need to be technical to use this?

Not at all. Enter your website URL and Pendium handles everything: scanning AI platforms, analyzing your visibility, generating content, and tracking improvement. The dashboard is designed for business owners, not engineers. If you can check your email, you can use Pendium.

What makes this different from SEO?

Traditional SEO optimizes for Google's search rankings — blue links on a results page. AI visibility is different: AI doesn't show links, it gives direct answers. Even if you rank #1 on Google, ChatGPT might recommend a competitor. Pendium optimizes for the new paradigm — making sure AI platforms know about, trust, and recommend your business.

Businesses/Biotechnology / Biopharmaceuticals/Moderna, Inc.

AI Visibility & Sentiment

Moderna, Inc.

Moderna is a pioneering biotechnology company that leverages messenger RNA (mRNA) technology to develop a new class of transformative medicines. By treating medicine like software code, the company creates instructions for human cells to produce proteins that prevent, treat, or cure a wide range of diseases including infectious diseases, cancer, and rare ailments.

Active Monitoring

modernatx.com

Biotechnology / Biopharmaceuticals

Partial scan

AI Visibility Score

94/100

Excellent

Sentiment Score

83/100

Score by Priority

How often this business is recommended to users across different types of conversations — from direct product queries to broader open-ended conversations where AI could recommend this company's products and services

core

adjacent

aspirational

AI Perception

Key Takeaways

How AI platforms collectively perceive and describe Moderna, Inc. today.

Moderna commands a dominant position in AI-driven search, consistently capturing top-tier visibility for its pioneering mRNA-based flu and oncology therapies. While the brand is a clear industry leader for specialized medical audiences, it faces a strategic blind spot in foundational corporate credibility queries where competitor narratives currently overshadow its footprint.

Working in your favor

Secures primary positioning for highly technical and clinical inquiries regarding individualized neoantigen therapies.

Maintains a perfect mention rate for key professional personas including Clinical Research Coordinators and Public Health Procurement Directors.

Leverages AI Overviews effectively to establish authority in mRNA vaccine comparisons against traditional technologies.

Gaps to close

Underperforms in brand-agnostic 'trust' and 'corporate credibility' searches where Moderna fails to appear as an industry benchmark.

Missing critical visibility in broad-market preventive care inquiries, specifically for RSV and COVID-19 booster decision-making.

Absence of brand reinforcement in general knowledge queries, signaling a weakness in top-of-funnel brand identity establishment.

Opportunities

Capitalize on the existing momentum in oncology to define the narrative around 'personalized cancer vaccines' before competitors consolidate the space.

Develop structured, authoritative content targeting the credibility gaps identified by procurement and trust-focused queries.

Strengthen the 'Preventive Care' content strategy to ensure Moderna remains the default answer for vaccine selection inquiries currently ceded to competitors.

Highest-Impact Actions

Develop and deploy an 'Industry Leadership and Credibility' content pillar focused on large-scale biotech manufacturing and quality assurance.

The current data shows a total absence in 'trusted biotech' and 'credibility evaluation' queries, allowing competitors to claim the narrative in high-stakes B2B search.

Optimize existing preventive care web assets to directly address specific RSV and COVID-19 booster selection criteria found in the AI Overview rankings.

Moderna is losing critical market share in consumer-facing vaccine queries where competitors like GSK and Pfizer are capturing the top search slots.

Launch a targeted digital campaign specifically curated for Clinical Research Coordinators to sustain and amplify the current top-positioning in therapeutic oncology.

While performance is strong here, maintaining this edge is vital to fending off encroaching competitors like BioNTech and those developing proprietary vaccines.

Value Proposition

Moderna’s proprietary mRNA platform functions as a standardized delivery system, allowing for the rapid design and scalable manufacturing of treatments for diseases previously considered undruggable.

Overview

Mission

To deliver on the promise of mRNA science to create a new generation of transformative medicines for patients.

Products & Services

Spikevax (COVID-19 Vaccine)mRESVIA (RSV Vaccine)mRNA-4157 (Individualized Neoantigen Therapy)mRNA-1010 (Seasonal Influenza Vaccine Candidate)mRNA-1647 (Cytomegalovirus Vaccine Candidate)

Current State

Visibility Landscape

A high-level view of how Moderna, Inc. performs across AI platforms, broken down by strategic priority level — from core brand queries to growth opportunities.

	ChatGPT	Claude	Gemini	AI Overviews
Reputation1q Brand recognition & direct queries	—	—	—	—
Core5q Product/service category queries	—	—	—	95
Growth Areas3q Adjacent, aspirational & visionary	—	—	—	—

Competitive Landscape

Moderna, Inc.6 mentions

GSK (Arexvy)2 mentions

Pfizer (Abrysvo)2 mentions

Merck2 mentions

Keytruda2 mentions

Autogene Cevumeran2 mentions

BioNTech2 mentions

NeoVax2 mentions

PGV0012 mentions

Mount Sinai2 mentions

Pfizer2 mentions

Analysis

Insights & Recommended Actions

What's working, what's not, and specific steps to improve Moderna, Inc.'s AI visibility.

Key Findings

Strength

Secures primary positioning for highly technical and clinical inquiries regarding individualized neoantigen therapies.

Strength

Maintains a perfect mention rate for key professional personas including Clinical Research Coordinators and Public Health Procurement Directors.

Strength

Leverages AI Overviews effectively to establish authority in mRNA vaccine comparisons against traditional technologies.

Recommended Actions

Develop and deploy an 'Industry Leadership and Credibility' content pillar focused on large-scale biotech manufacturing and quality assurance.

The current data shows a total absence in 'trusted biotech' and 'credibility evaluation' queries, allowing competitors to claim the narrative in high-stakes B2B search.

Optimize existing preventive care web assets to directly address specific RSV and COVID-19 booster selection criteria found in the AI Overview rankings.

Moderna is losing critical market share in consumer-facing vaccine queries where competitors like GSK and Pfizer are capturing the top search slots.

Launch a targeted digital campaign specifically curated for Clinical Research Coordinators to sustain and amplify the current top-positioning in therapeutic oncology.

While performance is strong here, maintaining this edge is vital to fending off encroaching competitors like BioNTech and those developing proprietary vaccines.

Programmatic Testing

Sample Conversations

We programmatically analyze questions that real customers are asking to AI agents and chatbots, extract brand mentions and sentiment, analyze every response, and synthesize the data into an action plan to increase AI visibility.

ChatGPT

Claude

Gemini

AI Overviews

Preventive Care And Vaccine Selection(3 queries)

“what are the best vaccine options for preventing rsv in older adults this year”

1/1 platforms mentioned

Core

AI Overviews

1.GSK (Arexvy)

2.Pfizer (Abrysvo)

3.Moderna (mResvia)

“compare the leading mrna based flu vaccine candidates to traditional ones”

1/1 platforms mentioned

Core

Public Health Procurement Director · Procurement Lead

AI Overviews

1.Pfizer

2.Moderna, Inc. (mRNA-1010, mRNA-1083)

“what should i look for in a covid-19 booster for the upcoming season”

0/0 platforms mentioned

Adjacent

Public Health Procurement Director · Procurement Lead

Source Intelligence

Citations

The sources AI platforms cite when recommending this brand. Pendium reverse-engineers what's already proven to be catnip to AI agents, then engineers content that fills gaps and helps agents do their job — which means more citations for you.

RSV Vaccine Guidance for Adults - CDC

cdc.gov

Gov1 ref

Vaccines for Adults | RSV - CDC

cdc.gov

Gov1 ref

CDC Updates RSV Vaccination Recommendations for Adults

physiciansweekly.com

Web1 ref

RSV Recommendations and Guidance | Johns Hopkins

publichealth.jhu.edu

Edu1 ref

Should You Get an RSV Vaccine? | News - Yale Medicine

yalemedicine.org

Web1 ref

RSV Vaccination in Adults: What Healthcare Providers Need ...

lung.org

Web1 ref

What is the difference between Arexvy and Abrysvo?

drugs.com

Web1 ref

RSV Vaccine for Older Adults: What You Need to Know in 2025

ncoa.org

Web1 ref

09/15/25 Health Advisory: 2025–2026 respiratory-illness ...

providerresourceswa.org

Web1 ref

Flu & RSV Vaccine Guide Fall 2025 | Side Effects, Costs ...

healthexpressuc.com

Web1 ref

Advancements and challenges in personalized neoantigen-based ...

pmc.ncbi.nlm.nih.gov

Gov1 ref

Neoantigen cancer vaccines: a new star on the horizon - PMC

pmc.ncbi.nlm.nih.gov

Gov1 ref

Personalized Cancer Vaccine Proves Promising in a Phase 1 Trial at ...

mountsinai.org

Web1 ref

Neoantigen-based immunotherapy: advancing precision medicine in ...

pmc.ncbi.nlm.nih.gov

Gov1 ref

Exploring individualized neoantigen therapies in cancer | STAT

statnews.com

Web1 ref

Engineer content that makes AI agents recommend you

Pendium analyzes how AI platforms perceive your brand, reverse-engineers what they already cite, and continuously publishes content designed to fill gaps and earn more mentions — on autopilot, with you in the loop.

Data generated by Pendium.ai AI visibility scanning. Last scanned March 16, 2026.